The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy/safety analysis of a phase 2 study of ruxolitinib (Rux) + regorafenib (Re) in patients (pts) with relapsed/refractory (r/r) metastatic colorectal cancer (mCRC).
 
David R. Fogelman
Research Funding - Incyte
 
Johanna C. Bendell
No Relationships to Disclose
 
Antonio Cubillo
No Relationships to Disclose
 
Pilar Garcia Alfonso
No Relationships to Disclose
 
María Luisa Limón Mirón
No Relationships to Disclose
 
John J. Nemunaitis
Employment - Gradalis
Leadership - Gradalis
Stock and Other Ownership Interests - Gradalis
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Speakers' Bureau - Amgen
Patents, Royalties, Other Intellectual Property - Gradalis
Travel, Accommodations, Expenses - Amgen; Baxalta; Takeda
 
Daniel Blake Flora
No Relationships to Disclose
 
Christophe Borg
No Relationships to Disclose
 
Laurent Mineur
No Relationships to Disclose
 
Jose M Vieitez
Honoraria - Amgen; Merck; Roche
Consulting or Advisory Role - Amgen; Merck; Roche
Speakers' Bureau - Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Amgen; Merck; Roche
 
Allen Lee Cohn
Honoraria - MedImmune; Taiho Pharmaceutical
Speakers' Bureau - MedImmune; Taiho Pharmaceutical
 
Gene Brian Saylors
Speakers' Bureau - Bristol-Myers Squibb; Merck
 
Albert Assad
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Julie C. Switzky
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Peter O'Neill
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Li Zhou
Employment - Incyte; Merck (I)
Stock and Other Ownership Interests - Array BioPharma; Cell Therapeutics; Celldex; Gilead Sciences; Incyte; Juno Therapeutics; Merck (I)
 
Mark D. Kochenderfer
No Relationships to Disclose